• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向PIK3R2的MicroRNA-126通过调控PTEN/PI3K/AKT信号通路抑制非小细胞肺癌A549细胞的增殖、迁移和侵袭

MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway.

作者信息

Song Lei, Li Dan, Gu Yue, Wen Zhong-Mei, Jie Jing, Zhao Dan, Peng Li-Ping

机构信息

Department of Respiratory Medicine, First Hospital of Jilin University, Changchun, People's Republic of China.

Department of Respiratory Medicine, First Hospital of Jilin University, Changchun, People's Republic of China.

出版信息

Clin Lung Cancer. 2016 Sep;17(5):e65-e75. doi: 10.1016/j.cllc.2016.03.012. Epub 2016 Apr 6.

DOI:10.1016/j.cllc.2016.03.012
PMID:27236384
Abstract

BACKGROUND

Our study explored whether the microRNA-126 (miR-126)-mediated PTEN/PI3K/AKT (phosphatase and tensin homology deleted on chromosome 10/phosphatidylinositol 3-kinase regulatory subunit-β/AKT) signaling pathway by targeting PIK3R2 affects the proliferation, migration, and invasion of non-small-cell lung cancer (NSCLC) A549 cells.

MATERIALS AND METHODS

Quantitative real-time polymerase chain reaction was used to measure the expression of miR-126 in A549 cells. The MTT (methyl thiazolyl tetrazolium) assay, cell scratch test, Transwell assay, and Western blot were used to detect the proliferation, migration, and invasion of A549 cells and protein expression in A549 cells, respectively.

RESULTS

The expression of miR-126 decreased and the expression of PIK3R2 increased in A549 cells (P < .05, for both). Upregulation of miR-126 resulted in the decrease of the proliferation, migration, and invasive abilities of A549 cells, the downregulation of the expression of PIK3R2, PI3K, and phosphorylated Akt (p-Akt) protein, and the upregulation of PTEN expression (P < .05 for all). Also, these abilities of A549 cells increased, and the expression of these 3 proteins was upregulated with downregulation of miR-126 (P < .05 for all). The results of the dual luciferase reporter gene assay showed that PIK3R2 was the target gene of miR-126. PIK3R2, PI3K, and p-Akt proteins were downregulated, but PTEN protein was upregulated as PIK3R2 was silenced or the inhibitor of the PTEN/PI3K/AKT signaling pathway increased. Also, downregulation of miR-126 with silencing of PIK3R2 or increasing the inhibitor of the pathway caused increased PI3K and p-Akt protein expression and increased active proliferation, migration, and invasive abilities of A549 cells (P < .05 for all).

CONCLUSION

The upregulation of miR-126 in NSCLC A549 cells can reduce the expression of the target gene PIK3R2 and influence the PTEN/PI3K/AKT signaling pathway, suppressing the proliferation, migration, and invasive abilities of A549 cells.

摘要

背景

我们的研究探讨了微小RNA-126(miR-126)通过靶向PIK3R2介导的PTEN/PI3K/AKT(第10号染色体上缺失的磷酸酶和张力蛋白同源物/磷脂酰肌醇3-激酶调节亚基-β/AKT)信号通路是否影响非小细胞肺癌(NSCLC)A549细胞的增殖、迁移和侵袭。

材料与方法

采用定量实时聚合酶链反应检测A549细胞中miR-126的表达。分别采用MTT(噻唑蓝)法、细胞划痕试验、Transwell试验和蛋白质免疫印迹法检测A549细胞的增殖、迁移和侵袭以及A549细胞中的蛋白质表达。

结果

A549细胞中miR-126表达降低,PIK3R2表达升高(两者P均<0.05)。miR-126的上调导致A549细胞的增殖、迁移和侵袭能力降低,PIK3R2、PI3K和磷酸化Akt(p-Akt)蛋白的表达下调,PTEN表达上调(所有P均<0.05)。此外,随着miR-126的下调,A549细胞的这些能力增强,这3种蛋白的表达上调(所有P均<0.05)。双荧光素酶报告基因检测结果显示PIK3R2是miR-126的靶基因。当PIK3R2沉默或PTEN/PI3K/AKT信号通路抑制剂增加时,PIK3R2、PI3K和p-Akt蛋白下调,但PTEN蛋白上调。此外,通过沉默PIK3R2或增加该通路抑制剂下调miR-126导致PI3K和p-Akt蛋白表达增加,A549细胞的活性增殖、迁移和侵袭能力增强(所有P均<0.05)。

结论

NSCLC A549细胞中miR-126的上调可降低靶基因PIK3R2的表达并影响PTEN/PI3K/AKT信号通路,抑制A549细胞的增殖、迁移和侵袭能力。

相似文献

1
MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway.靶向PIK3R2的MicroRNA-126通过调控PTEN/PI3K/AKT信号通路抑制非小细胞肺癌A549细胞的增殖、迁移和侵袭
Clin Lung Cancer. 2016 Sep;17(5):e65-e75. doi: 10.1016/j.cllc.2016.03.012. Epub 2016 Apr 6.
2
Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.微小RNA-135a通过IGF-1/PI3K/Akt信号通路对非小细胞肺癌细胞增殖、迁移、侵袭、凋亡及肿瘤血管生成的影响
Cell Physiol Biochem. 2017;42(4):1431-1446. doi: 10.1159/000479207. Epub 2017 Jul 17.
3
MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.微小RNA-106b通过靶向PTEN,经由PI3K/AKT信号通路促进垂体肿瘤细胞的增殖和侵袭。
Tumour Biol. 2016 Oct;37(10):13469-13477. doi: 10.1007/s13277-016-5155-2. Epub 2016 Jul 27.
4
miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.微小RNA-125b通过PI3K/Akt/GSK3β信号通路调节人非小细胞肺癌的细胞凋亡。
Oncol Rep. 2017 Sep;38(3):1715-1723. doi: 10.3892/or.2017.5808. Epub 2017 Jul 12.
5
MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.微小 RNA-92a 通过激活 PTEN/PI3K/AKT 信号通路促进非小细胞肺癌转移中的上皮-间充质转化。
Int J Oncol. 2017 Jul;51(1):235-244. doi: 10.3892/ijo.2017.3999. Epub 2017 May 16.
6
Downregulated microRNA-135a ameliorates rheumatoid arthritis by inactivation of the phosphatidylinositol 3-kinase/AKT signaling pathway via phosphatidylinositol 3-kinase regulatory subunit 2.下调 microRNA-135a 通过磷脂酰肌醇 3-激酶调节亚基 2 使磷脂酰肌醇 3-激酶/AKT 信号通路失活,从而改善类风湿关节炎。
J Cell Physiol. 2019 Aug;234(10):17663-17676. doi: 10.1002/jcp.28390. Epub 2019 Mar 25.
7
MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.miR-4299 通过调控 PTEN/AKT/PI3K 通路抑制非小细胞肺癌细胞的增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2018 Jun;22(11):3408-3414. doi: 10.26355/eurrev_201806_15163.
8
MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer.MicroRNA-4286 通过调控 PTEN 对 PI3K/Akt 通路促进非小细胞肺癌细胞的增殖、迁移和侵袭。
Cancer Med. 2019 Jul;8(7):3520-3531. doi: 10.1002/cam4.2220. Epub 2019 May 10.
9
MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.microRNA-629 通过靶向 FOXO1 并激活 PI3K/AKT 通路促进非小细胞肺癌的肿瘤发生。
Cancer Biomark. 2020;29(3):347-357. doi: 10.3233/CBM-201685.
10
MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.微小RNA-1靶向磷脂酰肌醇-4,5-二磷酸3-激酶催化亚基α并抑制A549细胞的致瘤特性。
Biomed Pharmacother. 2014 Mar;68(2):155-61. doi: 10.1016/j.biopha.2014.01.005. Epub 2014 Jan 15.

引用本文的文献

1
MicroRNA155 in non-small cell lung cancer: a potential therapeutic target.非小细胞肺癌中的微小RNA155:一个潜在的治疗靶点。
Front Oncol. 2025 Feb 3;15:1517995. doi: 10.3389/fonc.2025.1517995. eCollection 2025.
2
Oxidative stress in asthma pathogenesis: mechanistic insights and implications for airway smooth muscle dysfunction.哮喘发病机制中的氧化应激:作用机制及对气道平滑肌功能障碍的影响
Cell Tissue Res. 2025 Apr;400(1):17-34. doi: 10.1007/s00441-025-03953-7. Epub 2025 Feb 7.
3
MiRNAs and Microbiota in Non-Small Cell Lung Cancer (NSCLC): Implications in Pathogenesis and Potential Role in Predicting Response to ICI Treatment.
miRNAs 与非小细胞肺癌(NSCLC)中的微生物群:在发病机制中的意义及在预测 ICI 治疗反应中的潜在作用。
Int J Mol Sci. 2024 Jun 18;25(12):6685. doi: 10.3390/ijms25126685.
4
MicroRNA-126 (MiR-126): key roles in related diseases.miRNA-126(miR-126):相关疾病中的关键作用。
J Physiol Biochem. 2024 May;80(2):277-286. doi: 10.1007/s13105-024-01017-y. Epub 2024 Mar 22.
5
MicroRNA-126 selected with broad-spectrum analysis of microRNAs - a new predictive factor for the effectiveness of immunotherapy or chemoimmunotherapy in advanced NSCLC patients?通过对微小RNA进行广谱分析筛选出的微小RNA-126——晚期非小细胞肺癌患者免疫治疗或化疗免疫治疗疗效的新预测因子?
Front Immunol. 2024 Feb 26;15:1344858. doi: 10.3389/fimmu.2024.1344858. eCollection 2024.
6
Association of ATG10 rs1864183, ATG16L1 rs2241880 and miR-126 with esophageal cancer.ATG10 rs1864183、ATG16L1 rs2241880 和 miR-126 与食管癌的关联。
Mol Biol Rep. 2024 Jan 28;51(1):231. doi: 10.1007/s11033-023-09012-0.
7
Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer.微小RNA对非小细胞肺癌的调控作用及治疗潜力
Heliyon. 2023 Nov 14;9(11):e22080. doi: 10.1016/j.heliyon.2023.e22080. eCollection 2023 Nov.
8
Exosomal microRNA Therapy for Non-Small-Cell Lung Cancer.外泌体 microRNA 治疗非小细胞肺癌。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231210731. doi: 10.1177/15330338231210731.
9
LncRNA HOTAIR regulates the PI3K/AKT pathway via the miR-126-3p/PIK3R2 axis to participate in synovial angiogenesis in rheumatoid arthritis.长链非编码 RNA HOTAIR 通过 miR-126-3p/PIK3R2 轴调控 PI3K/AKT 通路参与类风湿关节炎滑膜血管生成。
Immun Inflamm Dis. 2023 Oct;11(10):e1064. doi: 10.1002/iid3.1064.
10
Unraveling Therapeutic Opportunities and the Diagnostic Potential of microRNAs for Human Lung Cancer.揭示微小RNA在人类肺癌中的治疗机会和诊断潜力
Pharmaceutics. 2023 Jul 31;15(8):2061. doi: 10.3390/pharmaceutics15082061.